郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity.

期刊:Molecular pharmacology发表年份:2013作者:Gemma L Baillie; James G Horswill; Sharon Anavi-Goffer; Patricia H Reggio; Daniele Bolognini; Mary E Abood; Sean McAllister; Phillip G Strange; Gary J Stephens; Roger G Pertwee; Ruth A Ross

药效评价Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111.

期刊:British journal of pharmacology发表年份:2013作者:M Marti; F Mela; M Budri; M Volta; D Malfacini; S Molinari; N T Zaveri; S Ronzoni; P Petrillo; G Calò; M Morari

药效评价Interaction of D₃ preferring agonist (-)-N⁶-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N⁶-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264) with cloned human D₂L, D₂S, and D₃ receptors: potent stimulation of mitogen-activated protein kina

期刊:Naunyn-Schmiedeberg's archives of pharmacology发表年份:2013作者:Eldo V Kuzhikandathil; Samantha Cote; Soumava Santra; Aloke K Dutta

药效评价Signaling of an allosteric, nanomolar potent, low molecular weight agonist for the follicle-stimulating hormone receptor.

期刊:Biochemical pharmacology发表年份:2013作者:Chris J van Koppen; Pieter M Verbost; Ruud van de Lagemaat; Willem-Jan F Karstens; Huub J J Loozen; Tanja A E van Achterberg; Monique G A van Amstel; Jolanda H G M Brands; Els J P van Doornmalen; Jesse Wat; Saskia J Mulder; Bianca C Raafs; Saskia Ver